
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation on Wednesday. (Image: Social Security Works)
Democrats Who Approved 'Greedy Big Pharma CEO' for HHS Secretary Should Be Ashamed: Critics
"Shame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry."
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. The final deadline for our crucial Summer Campaign fundraising drive is just days away, and we’re falling short of our must-hit goal. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."